S
Skye Bioscience
0 followers
Skye Bioscience (OTC: SKYE) is a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant unmet medical needs.
Org chart
Collapse
Kaitlyn Arsenault
Chief Financial Officer
Tu Diep
Chief Development Officer
Chris Twitty
Chief Scientific Officer
Karam Takhar
VP, Corporate Development & Investor Relations
Annalisa Jenkins
Non Executive Board Member
Board & advisors
Margaret Dalesandro
Director
Eduardo Muñoz
Scientific Advisor
Giovanni Appendino
Scientific Advisor
Jeffrey Goldberg
Clinical Advisor
Louis Pasquale
Clinical Advisor
Robert Ritch
Clinical Advisor
Miguel González-Andrades
Clinical Advisor
Deborah Charych
Director
Paul Grayson
Director
Andy Schwab
Director
Teams
Offices
Similar companies
Arthritis Knee Pain Centers
2 followers
Bristol-Myers Squibb
225 followers
NYU Langone Health
16 followers
West Pharmaceutical Services
8 followers
Curia Global
5 followers
AbbVie
224 followers
Navitus Health
3 followers
HistoSonics
3 followers
Xeris Pharmaceuticals
2 followers
Corcept Therapeutics
4 followers
Rocket Pharmaceuticals
2 followers
Explore companies